Global Cell/Tissue Culture Supplies Industry

NEW YORK, Nov. 29, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Cell/Tissue Culture Supplies Industry

http://www.reportlinker.com/p098415/Global-Cell/Tissue-Culture-Supplies-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

This report analyzes the worldwide markets for Cell/Tissue Culture Supplies in US$ Million by the following Product Segments: Media, Sera, and Reagents. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 92 companies including many key and niche players such as Affymetrix, Inc., AMRESCO, Inc., BD Biosciences, Cell Culture Technologies, LLC, Cell Essentials, Inc., EMD Millipore, Irvine Scientific, Life Technologies Corporation, Lonza Biologics Plc, Mediatech, Inc., Millipore Corporation, Medi-Cult A/S, MP Biomedicals, PerBio Science AB, PromoCell GmbH, Sera Laboratories International, Sigma-Aldrich Corporation, SAFC Biosciences, and Vitrolife AB. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

Cell/Tissue Culture Media, Sera and Reagents I-3

Media I-3

Sera I-4

Reagents I-4

II. EXECUTIVE SUMMARY

1. MARKET DYNAMICS II-1

Outlook II-1

Biopharmaceutical Drugs Fuel Cell Culture Market II-1

Regenerative Medicine Kindles Exciting Prospects for Cell/

Tissue Culture Supplies Market II-2

Table 1: Global Market for Tissue Engineering and

Orthopedic/Spine Cell Therapy (2010): Percentage Share

Breakdown for Stryker, DuPuy, Medtronic, Zimmer, and Others

(includes corresponding Graph/Chart) II-3

Market Scenario II-3

Industrial vs. Academic II-3

Biotechnology Sector - Affected by Collapse of Capital Market II-3

Market Structure II-4

2. TRENDS AND ISSUES II-5

3D Technology to Put a New Spin on In Vitro Cell Analyses II-5

US Government's Policies to Boost Cell Culture Market II-5

Surging Demand for Cell Culture Products II-5

Stem Cells and Vaccines - Key Drivers II-6

Growing Acceptance for Hi-Veg Culture Media II-6

Fed-Batch Cultures - A Big Hit with Large-Scale Bioprocessors II-6

Changing Trend towards Serum-Free Media II-7

Proteomics and Pharmacokinetics to Drive Market Growth II-7

Bioresearch and Cell Culture in Protein Based Drug Development II-8

CHO, Hybridomas and Mabs Dominate Mammalian Cell Culture II-8

Sluggish Fetal Bovine Serum Market II-9

Specialty Media Demand on Rise II-9

Emerging Alternatives to Conventional Serum Supplemented Media II-9

Growth of Defined Media II-10

Regulations Prompt Change in Trends II-10

Media Optimization II-10

Cell-Line Engineering Vs. Cell Culture Media II-10

Other Trends II-10

Underlying Threat to Cell Culture Industry II-11

Manufacture-on-Demand: Gaining Momentum II-11

Move towards Contract Manufacturing II-11

Factors Impacting Growth II-11

Business Models Driving the Need for Contract Manufacturing II-12

Trends in Contract Manufacturing II-12

Target Sectors for Contract Manufacturers II-12

3. END-USE ANALYSIS II-13

End-Use Applications II-13

Cell Therapy II-13

Growing by Leaps and Bounds II-13

Cell Therapy Applications II-14

Key Factors Affecting the Cell Therapy Market II-14

Future Trends II-14

Related Market Sectors II-14

Progenitor Cell Therapy II-14

Stem Cell Therapy II-15

Other Related Technologies II-16

Somatic Cell Nuclear Transfer (SCNT) II-16

Tissue Engineering II-16

End Use Industries II-16

4. CELL/TISSUE CULTURE: PHYSIOLOGICAL OVERVIEW II-17

Introduction II-17

History II-17

Plant Culture: The Timeline II-17

Plant Cell and Tissue Culture (PCTC) II-21

Plant Tissue Culture Techniques and Applications II-22

Cell/Tissue Culture Media, Sera and Reagents II-25

Classical Media II-25

Specialty Media II-25

Serum II-25

Fetal Bovine Serum II-26

Serum-Free Media II-26

Cell Culture Reagents II-26

Role of Tissue Culture in the Growth of Cell Types II-26

Equipment II-26

Storage and Preservation II-27

Maintenance II-27

Growth Pattern II-27

Harvesting II-27

Suspension Cultures II-28

Adherent Cultures II-28

Mechanical II-28

Proteolytic Enzymes II-28

Standard Procedure for Detaching Adherent Cells II-28

Media and Growth Requirements II-28

Physiological Parameters II-28

Medium Requirements (Often Empirical) II-29

Feeding II-29

Safety Precautions II-29

Methods of Tissue Culture II-29

Preparation of Media II-29

Growth and Morphology II-30

Sub Culturing Adherent Cells II-30

Thawing Frozen Cells II-30

Freezing Cells II-30

3D Culture-Enabling Technologies II-30

Natural Scaffold Substrates II-30

Hydrogels II-30

Inert Non-Degradable Scaffolds II-31

Biodegradable Materials II-31

Cell Culture Contamination - A Looming Problem II-31

Classification II-31

Minor Annoyances II-32

Serious Problems II-32

Major Catastrophes II-32

Major Cell Culture Contaminants II-32

Chemical Contamination II-32

Types and Sources of Potential Chemical Contaminants II-32

Varied Sources of Chemical Contamination II-32

Media and Components II-33

Sera II-33

Water II-33

Storage Vessels II-34

Fluorescent Lights II-34

Endotoxins II-34

Incubators II-34

Biological Contamination II-35

Varied Sources of Biological Contamination II-35

Mycoplasmas II-35

Levels of Cell Culture Contamination Caused by Mycoplasma II-36

Airborne Particles and Aerosols II-36

Cross Contamination by Other Cell Cultures II-36

Consequences/Problems of Contamination II-36

Controlling Cell Culture Contamination II-37

Measures Aimed at Reducing Contamination Problems II-37

5. PRODUCT INNOVATIONS/INTRODUCTIONS II-38

PhoenixSongs Launches New Neural Cell Culture Media II-38

Selexis Unveils BalanCD CHO SLX A II-38

Irvine Launches BalanCD™ Cell Culture Media Product Series II-39

Thermo Fisher Launches HyCell CHO Cell-Culture Medium II-39

Corning Introduces Corning cellgro® II-40

StemCells Introduces 3 New Cell Culture Supplements II-40

SAFC® Launches New CHOZN® GS-/- Zinc Finger Nuclease-modified

Chinese Hamster Ovary Cell Line II-41

SAFC® Introduces First Product of ZFN-Modified Chinese Hamster

Ovary Cell Lines II-41

ORIGIO Unveils EmbryoGen® In Vitro Fertilization Medium II-42

6. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST - A PERSPECTIVE

BUILDER II-43

Charter Medical Unveils Pharmaceutical and Biotech Processing

Bio-Pak® Cell Culture Bags II-43

Vitrolife Unveils World's First Biorisk-Free Cytokines and

Growth Factors II-43

Millipore Launches EpiGro Epithelial Cells and Culture Media II-43

StemCells Unveils GS2-M Medium for Cell Culture II-44

StemCells Introduces GS1-R™ II-44

Kollodis BioSciences Introduces Cell-Culture Reagents II-44

The Automation Partnership Launches Automated Cell-Culture II-44

Novartis Receives Approval to Release New Vaccine II-45

Invitrogen Introduces GIBCO® OpTmizer TM T-cell Expansion SFM II-45

Novozymes Biopharma Rolls Out CellPrime in Partnership with

Millipore II-45

Invitrogen Launches Dynabeads® SSEA-4 II-46

Invitrogen Rolls Out KNOCKOUT™ SR XenoFree Media II-46

Lonza Develops One-Step Program II-46

Millipore Unveils ESGRO Complete™ PLUS Medium II-46

Millipore Introduces Hanging Millicell® Cell Culture Inserts II-46

SAFC Biosciences® Launches EX-CELLTM EBx® II-47

SAFC Biosciences® Rolls Out EX-Fusion and CHO Library II-47

7. RECENT INDUSTRY ACTIVITY II-48

EMD Millipore Takes Over Biochrom II-48

Kerry Ingredients & Flavours Establishes Cell Science

Laboratory at Customer Center of Excellence II-48

Merck KGaA Takes Over Beijing Skywing Technology II-48

Corning Takes Over Mediatech II-49

GE Healthcare Takes Over PAA II-49

Compass Expands Partnership with PanGen II-49

Miltenyi Enters into Partnership with TeutoCell II-50

SAFC® Enters into Licensing Deal with Agilent II-50

Life Technologies Obtains FDA Clearance to Launch StemPro® MSC

SFM II-51

Transparent Inks Agreement with Molecular Response II-51

Wockhardt Inks Agreement with Sheffield Bio-Science II-52

8. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER II-53

PX'Therapeutics to Establish cGMP Production Unit II-53

BioTime Asia Signs Marketing Agreement with Shanghai Genext

Medical Technology II-53

EHSI Acquires Synthecon's Bioreactor II-53

Essential Pharmaceuticals Inks Agreement with Lifeblood Medical II-54

Vitro Revises Agreement with HemoGenix II-54

International Stem Cell Corporation Enters into Agreement with

Insight Bioventures India to Establish ISCO India II-54

GCS Inks Agreement with VWR II-55

Irvine Scientific Opens New Industrial Cell Culture Media

Production Unit in Tokyo II-56

BioTime to Introduce 7 Novel Human Embryonic Progenitor Cell

Lines and 7 New Culture Media II-56

Lifeline Cell Technology Enters into Distribution Agreement

with Sristi Biosciences II-57

Reinnervate Obtains Investment to Realize Commercial Viability

of Alvetex® 3D Cell Culture Platform II-57

American CryoStem Obtains Patent for 'Cell Culture Media,

Kits, and Methods of Use' II-57

Akron Biotechnology Merges with AppliChem II-58

ChanTest Takes Over Applied Cell Sciences II-58

Millipore Takes Over Guava Technologies II-58

Millipore Acquires EpiTag™ Technology from Epitome Biosystems II-59

MediCult's BlastAssist® Culture Media Obtains FDA Approval II-59

Capsant Signs Commercialization Agreement with VistaGen II-59

9. FOCUS ON SELECT PLAYERS II-60

Affymetrix, Inc. (US) II-60

AMRESCO, Inc. (US) II-60

BD Biosciences (US) II-60

Cell Culture Technologies, LLC (Switzerland) II-61

Cell Essentials, Inc. (US) II-61

Corning, Inc. (US) II-61

EMD Millipore (US) II-62

Irvine Scientific, Inc. (US) II-62

Life Technologies Corporation (US) II-62

Lonza Biologics Plc (UK) II-63

MP Biomedicals LLC (US) II-63

ORIGIO a/s (Denmark) II-63

PromoCell GmbH (Germany) II-63

Sera Laboratories International Ltd (UK) II-64

Sigma-Aldrich Corporation (US) II-64

SAFC Biosciences, Inc. (US) II-65

Thermo Fisher Scientific, Inc. (US) II-65

Vitrolife AB (Sweden) II-65

10. GLOBAL MARKET PERSPECTIVE II-66

Table 2: World Recent Past, Current & Future Analysis for

Cell/Tissue Culture Supplies by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan) and

Latin American Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) II-66

Table 3: World Historic Review for Cell/Tissue Culture

Supplies by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan) and Latin American Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-67

Table 4: World 15-Year Perspective for Cell/Tissue Culture

Supplies by Geographic Region - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan) & Latin America Markets for Years 2004, 2011 & 2018

(includes corresponding Graph/Chart) II-68

Cell/Tissue Culture Supplies Market by Product Segment II-69

Table 5: World Recent Past, Current & Future Analysis for

Media Cell/Tissue Culture Supplies by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan) and

Latin American Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) II-69

Table 6: World Historic Review for Media Cell/Tissue Culture

Supplies by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan) and Latin American Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-70

Table 7: World 15-Year Perspective for Media Cell/ Tissue

Culture Supplies by Geographic Region - Percentage Breakdown

of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan) & Latin America Markets for Years 2004, 2011

& 2018 (includes corresponding Graph/Chart) II-71

Table 8: World Recent Past, Current & Future Analysis for Sera

Cell/Tissue Culture Supplies by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan) and

Latin American Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) II-72

Table 9: World Historic Review for Sera Cell/Tissue Culture

Supplies by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan) and Latin American Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-73

Table 10: World 15-Year Perspective for Sera Cell/ Tissue

Culture Supplies by Geographic Region - Percentage Breakdown

of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan) & Latin America Markets for Years 2004, 2011 &

2018 (includes corresponding Graph/Chart) II-74

Table 11: World Recent Past, Current & Future Analysis for

Reagent Cell/Tissue Culture Supplies by Geographic Region -

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and

Latin American Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) II-75

Table 12: World Historic Review for Reagent Cell/ Tissue

Culture Supplies by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan) and Latin American

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) II-76

Table 13: World 15-Year Perspective for Reagent Cell/Tissue

Culture Supplies by Geographic Region - Percentage Breakdown

of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan) & Latin America Markets for Years 2004, 2011 &

2018 (includes corresponding Graph/Chart) II-77

III. MARKET

1. THE UNITED STATES III-1

A.Market Analysis III-1

Current and Future Analysis III-1

Cell & Tissue Culture Market III-1

A Brief Insight III-1

Market Trends III-2

Trend Towards Serum-Free Media III-2

Liquid and Powdered Media Account for Major Share III-2

Table 14: Leading Players in the US Cell Culture Media

Market (2010): Percentage Breakdown of Sales for

Sigma-Aldrich, Hyclone, Lonza Biologics, and Others

(includes corresponding Graph/Chart) III-2

Fetal Bovine Serum - On a Decline III-3

Rise in Cell Culture Equipment Demand Leads to Innovation III-3

Market for Stem Cell Research III-3

End-Use Analysis III-4

Table 15: US Market for Cell Culture Reagents (2010):

Percentage Breakdown by End-Use for Academic, Industrial,

and Non-Academic (includes corresponding Graph/Chart) III-4

Factors Influencing Tissue and Cell Culture Media Market III-4

Regulatory Controls III-4

Guidelines Governing Use of Cell/Tissue Culture Reagents III-5

MSDS and Hazardous Information III-5

Toxic Substances Control Act III-5

Regulatory Environment III-5

Major FDA Regulations III-6

Export/Import Stats - A Historic Perspective III-6

Table 16: US Imports of Preparation Culture Media for the

Development of Microorganisms and Plant/Human/Animal Cells

(2009): Percentage Breakdown of Import Value by Country

(includes corresponding Graph/Chart) III-6

Table 17: US Exports of Preparation Culture Media for the

Development of Microorganisms and Plant/Human/Animal Cells

(2009): Percentage Breakdown of Export Value by Country

(includes corresponding Graph/Chart) III-7

Strategic Corporate Developments III-7

Product Launches III-10

Key Players III-13

B.Market Analytics III-18

Table 18: US Recent Past, Current & Future Analysis for

Cell/Tissue Culture Supplies by Product Segment - Media,

Sera, and Reagents Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2010 through

2018 (includes corresponding Graph/Chart) III-18

Table 19: US Historic Review for Cell/Tissue Culture

Supplies by Product Segment - Media, Sera, and Reagents

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-19

Table 20: US 15-Year Perspective for Cell/ Tissue Culture

Supplies by Product Segment - Percentage Breakdown of Dollar

Sales for Media, Sera, and Reagents Markets for Years 2004,

2011 & 2018 (includes corresponding Graph/Chart) III-20

2. CANADA III-21

A.Market Analysis III-21

Current and Future Analysis III-21

Biotechnology Industry III-21

B.Market Analytics III-22

Table 21: Canadian Recent Past, Current & Future Analysis

for Cell/Tissue Culture Supplies by Product Segment - Media,

Sera, and Reagents Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2010 through

2018 (includes corresponding Graph/Chart) III-22

Table 22: Canadian Historic Review for Cell/ Tissue Culture

Supplies by Product Segment - Media, Sera, and Reagents

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-23

Table 23: Canadian 15-Year Perspective for Cell/Tissue

Culture Supplies by Product Segment - Percentage Breakdown

of Dollar Sales for Media, Sera, and Reagents Markets for

Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) III-24

3. JAPAN III-25

A.Market Analysis III-25

Current and Future Analysis III-25

Strategic Corporate Development III-25

B.Market Analytics III-26

Table 24: Japanese Recent Past, Current & Future Analysis

for Cell/Tissue Culture Supplies by Product Segment - Media,

Sera, and Reagents Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2010 through

2018 (includes corresponding Graph/Chart) III-26

Table 25: Japanese Historic Review for Cell/Tissue Culture

Supplies by Product Segment - Media, Sera, and Reagents

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-27

Table 26: Japanese 15-Year Perspective for Cell/Tissue

Culture Supplies by Product Segment - Percentage Breakdown

of Dollar Sales for Media, Sera, and Reagents Markets for

Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) III-28

4. EUROPE III-29

A.Market Analysis III-29

Current and Future Analysis III-29

Market Overview III-29

B.Market Analytics III-30

Table 27: European Recent Past, Current & Future Analysis

for Cell/Tissue Culture Supplies by Geographic Region -

France, Germany, Italy, UK and Rest of Europe Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-30

Table 28: European Historic Review for Cell/Tissue Culture

Supplies by Geographic Region - France, Germany, Italy, UK

and Rest of Europe Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2004 through

2009 (includes corresponding Graph/Chart) III-31

Table 29: European 15-Year Perspective for Cell/Tissue

Culture Supplies by Geographic Region - Percentage Breakdown

of Dollar Sales for France, Germany, Italy, UK and Rest of

Europe Markets for Years 2004, 2011 & 2018 (includes

corresponding Graph/Chart) III-32

Table 30: European Recent Past, Current & Future Analysis

for Cell/Tissue Culture Supplies by Product Segment - Media,

Sera, and Reagents Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2010 through

2018 (includes corresponding Graph/Chart) III-33

Table 31: European Historic Review for Cell/ Tissue Culture

Supplies by Product Segment - Media, Sera, and Reagents

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-34

Table 32: European 15-Year Perspective for Cell/Tissue

Culture Supplies by Product Segment - Percentage Breakdown

of Dollar Sales for Media, Sera, and Reagents Markets for

Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) III-35

4a. FRANCE III-36

A.Market Analysis III-36

Current and Future Analysis III-36

B.Market Analytics III-36

Table 33: French Recent Past, Current & Future Analysis for

Cell/Tissue Culture Supplies by Product Segment - Media,

Sera, and Reagents Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2010 through

2018 (includes corresponding Graph/Chart) III-36

Table 34: French Historic Review for Cell/Tissue Culture

Supplies by Product Segment - Media, Sera, and Reagents

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-37

Table 35: French 15-Year Perspective for Cell/ Tissue

Culture Supplies by Product Segment - Percentage Breakdown

of Dollar Sales for Media, Sera, and Reagents Markets for

Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) III-38

4b. GERMANY III-39

A.Market Analysis III-39

Current and Future Analysis III-39

Biotech Research Scenario III-39

Table 36: German Biotech Market - A Historic Perspective

(2009): Percentage Breakdown by Application Area for

Environment, Human Health Care, Chemical industry, Food,

Agriculture, Energy, and Others (includes corresponding

Graph/Chart) III-40

Strategic Corporate Developments III-40

PromoCell GmbH - A Key Player III-41

B.Market Analytics III-42

Table 37: German Recent Past, Current & Future Analysis for

Cell/Tissue Culture Supplies by Product Segment - Media,

Sera, and Reagents Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2010 through

2018 (includes corresponding Graph/Chart) III-42

Table 38: German Historic Review for Cell/Tissue Culture

Supplies by Product Segment - Media, Sera, and Reagents

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-43

Table 39: German 15-Year Perspective for Cell/Tissue Culture

Supplies by Product Segment - Percentage Breakdown of Dollar

Sales for Media, Sera, and Reagents Markets for Years 2004,

2011 & 2018 (includes corresponding Graph/Chart) III-44

4c. ITALY III-45

A.Market Analysis III-45

Current and Future Analysis III-45

B.Market Analytics III-45

Table 40: Italian Recent Past, Current & Future Analysis for

Cell/Tissue Culture Supplies by Product Segment - Media,

Sera, and Reagents Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2010 through

2018 (includes corresponding Graph/Chart) III-45

Table 41: Italian Historic Review for Cell/Tissue Culture

Supplies by Product Segment - Media, Sera, and Reagents

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-46

Table 42: Italian 15-Year Perspective for Cell/ Tissue

Culture Supplies by Product Segment - Percentage Breakdown

of Dollar Sales for Media, Sera, and Reagents Markets for

Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) III-47

4d. THE UNITED KINGDOM III-48

A.Market Analysis III-48

Current and Future Analysis III-48

Biotechnology Industry - A Brief Insight III-48

Regulatory Issues III-49

HFE Act Guidelines III-49

Ethical Issues III-49

Key Players III-50

B.Market Analytics III-51

Table 43: UK Recent Past, Current & Future Analysis for

Cell/Tissue Culture Supplies by Product Segment - Media,

Sera, and Reagents Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2010 through

2018 (includes corresponding Graph/Chart) III-51

Table 44: UK Historic Review for Cell/Tissue Culture

Supplies by Product Segment - Media, Sera, and Reagents

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-52

Table 45: UK 15-Year Perspective for Cell/ Tissue Culture

Supplies by Product Segment - Percentage Breakdown of Dollar

Sales for Media, Sera, and Reagents Markets for Years 2004,

2011 & 2018 (includes corresponding Graph/Chart) III-53

4e. REST OF EUROPE III-54

A.Market Analysis III-54

Current and Future Analysis III-54

Scenario in other European Countries III-54

Strategic Coprorate Development III-54

Product Launches III-55

Key Players III-56

B.Market Analytics III-57

Table 46: Rest of Europe Recent Past, Current & Future

Analysis for Cell/Tissue Culture Supplies by Product Segment -

Media, Sera, and Reagents Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2010

through 2018 (includes corresponding Graph/Chart) III-57

Table 47: Rest of Europe Historic Review for Cell/ Tissue

Culture Supplies by Product Segment - Media, Sera, and

Reagents Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-58

Table 48: Rest of Europe 15-Year Perspective for Cell/Tissue

Culture Supplies by Product Segment - Percentage Breakdown

of Dollar Sales for Media, Sera and Reagent Markets for

Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) III-59

5. ASIA-PACIFIC III-60

A.Market Analysis III-60

Current and Future Analysis III-60

Rise of Cell Culture in Asia III-60

Overview of Select Markets III-60

Australia III-60

China III-60

India III-61

Cell Culture Market Constituents III-61

Taiwan III-61

Strategic Corporate Developments III-62

B.Market Analytics III-63

Table 49: Asia-Pacific Recent Past, Current & Future

Analysis for Cell/Tissue Culture Supplies by Product Segment -

Media, Sera, and Reagents Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2010

through 2018 (includes corresponding Graph/Chart) III-63

Table 50: Asia-Pacific Historic Review for Cell/ Tissue

Culture Supplies by Product Segment - Media, Sera, and

Reagents Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-64

Table 51: Asia-Pacific 15-Year Perspective for Cell/Tissue

Culture Supplies by Product Segment - Percentage Breakdown

of Dollar Sales for Media, Sera and Reagent Markets for

Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) III-65

6. LATIN AMERICA III-66

A.Market Analysis III-66

Current and Future Analysis III-66

Brazilian Biotech Industry - An Overview III-66

B.Market Analytics III-67

Table 52: Latin American Recent Past, Current & Future

Analysis for Cell/Tissue Culture Supplies by Product Segment -

Media, Sera, and Reagents Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2010

through 2018 (includes corresponding Graph/Chart) III-67

Table 53: Latin American Historic Review for Cell/ Tissue

Culture Supplies by Product Segment - Media, Sera, and

Reagents Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-68

Table 54: Latin American 15-Year Perspective for Cell/Tissue

Culture Supplies by Product Segment - Percentage Breakdown

of Dollar Sales for Media, Sera and Reagent Markets for

Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) III-69

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 92 (including Divisions/Subsidiaries - 104)

The United States (58)

Canada (3)

Japan (3)

Europe (33)

- France (2)

- Germany (9)

- The United Kingdom (12)

- Spain (1)

- Rest of Europe (9)

Asia-Pacific (Excluding Japan) (6)

Latin America (1)

To order this report:

In_Vitro_Diagnostic Industry: Global Cell/Tissue Culture Supplies Industry

Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.